Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China flag China · Delayed Price · Currency is CNY
29.00
-0.54 (-1.83%)
At close: Aug 24, 2026

SHA:688139 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
2,4252,3162,2742,2722,8552,119
Other Revenue
5.0412.29.859.248.627.31
2,4302,3292,2842,2812,8642,126
Revenue Growth
7.70%1.96%0.13%-20.36%34.72%51.63%
Cost of Revenue
1,2881,2471,1901,1741,4901,061
Gross Profit
1,1421,0821,0941,1071,3741,065
Selling, General & Admin
584.7552.22471.73476.68513.72388.03
Research & Development
335.64323.25306.17320.64292.47236.31
Other Operating Expenses
-1.2-2.74-6.48-7.252.341.63
Operating Expenses
919.59885.88787.08793.97809.08622.71
Operating Income
222.42195.77306.58312.95564.67441.98
Interest Expense
-3.82-3.91-3.41-3.51-2.69-2.89
Interest & Investment Income
52.9462.6871.46118.6495.02483.95
Currency Exchange Gain (Loss)
-7.16-2.384.46-7.723.584.14
Other Non Operating Income (Expenses)
-11.72-3.44-1.87-1.64-1.490.56
EBT Excluding Unusual Items
252.66248.72377.21418.71659.1927.74
Gain (Loss) on Sale of Investments
-0.17-0.495.472.06-7.0110.21
Gain (Loss) on Sale of Assets
0.560.630.23-1.6-0.76-0.52
Asset Writedown
-3.46-1.23-1.86-2.36--
Other Unusual Items
15.4417.1320.917.692423.44
Pretax Income
265.03264.76401.96434.49675.34960.87
Income Tax Expense
8.29.6320.9522.4363.36111.7
Earnings From Continuing Operations
256.83255.13381.01412.06611.97849.17
Minority Interest in Earnings
-1.43-4.4-14.38-5.99-11.18-4.14
Net Income
255.41250.73366.63406.07600.79845.04
Net Income to Common
255.41250.73366.63406.07600.79845.04
Net Income Growth
-7.13%-31.61%-9.71%-32.41%-28.90%121.82%
Shares Outstanding (Basic)
312313316317318316
Shares Outstanding (Diluted)
312313316317318318
Shares Change
-1.48%-0.84%-0.37%-0.20%0.06%-2.43%
EPS (Basic)
0.820.801.161.281.892.67
EPS (Diluted)
0.820.801.161.281.892.66
EPS Growth
-5.74%-31.03%-9.38%-32.27%-28.95%127.35%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
289.88148.64164.9672.08338.18387.11
Free Cash Flow Per Share
0.930.470.520.231.061.22
Dividend Per Share
0.3300.3300.4700.5150.4500.500
Dividend Growth
-29.79%-29.79%-8.74%14.44%-10.02%31.61%
Gross Margin
47.00%46.45%47.89%48.53%47.97%50.08%
Operating Margin
9.15%8.41%13.42%13.72%19.72%20.79%
Profit Margin
10.51%10.77%16.05%17.80%20.98%39.75%
Free Cash Flow Margin
11.93%6.38%7.22%3.16%11.81%18.21%
EBITDA
337.94303.74422.71410.67626.73491.15
EBITDA Margin
13.91%13.04%18.51%18.00%21.88%23.10%
D&A For EBITDA
115.52107.97116.1397.7262.0649.17
EBIT
222.42195.77306.58312.95564.67441.98
EBIT Margin
9.15%8.41%13.42%13.72%19.72%20.79%
Effective Tax Rate
3.09%3.64%5.21%5.16%9.38%11.63%
Revenue as Reported
2,4302,3292,2842,2812,8642,126
Advertising Expenses
-35.1624.8831.8225.4114.24